This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
 
Warren Buffett's Drywall Play Bets on USG Paying off on Construction

USG Corp. has burned Warren Buffett before -- the Oracle of Omaha ate it in 2000, after his bet on the drywall materials company went sour.

Palo Alto Networks, Workday Earnings, Jim Cramer's Dollar General Pick

USG Corp. has burned Warren Buffett before -- the Oracle of Omaha ate it in 2000, after his bet on the drywall materials company went sour.

German Confidence Boosts European Markets Amid Cross Border Mergers and Acquisitions Action

European markets rally, as London treads water. German business confidence index could spell brighter outlook for Europe’s largest economy.

What to Watch on Wall Street for the Week of November 24th 2014

For the week ahead, we note Wall Street's holiday schedule as Thanksgiving and Black Friday are coming up.

Tony Robbins: Best Investors Take Least Risk for Largest Rewards

The world's best investors take the least amount of risk for the largest rewards, said Tony Robbins, author of 'Money: Master The Game'.

Real Money Previews

Upbeat on Bon-Ton and Energy; Short Consumer Staples: Best of Kass

In highlights from his trading diary of the past week, Doug Kass discusses why he's net-short amid slowing global growth, with some bright spots being Bon-Ton and the energy sector.

PPG Is Spot-On; The Hazards of Skepticism: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about PPG's Mexico deal and the market's amazing run.

Jim Cramer on His Dad: ‘Our Last Day Together Was Our Best One’

A tribute to Ken Cramer, or 'Pop', father of TheStreet.com founder, 'Jimmy'.

Mad Money Recap

'Mad Money' Lightning Round: I'll Take Popeyes Over Wendy's

Cramer can't recommend Dynavax Technologies but wants you to hold Noble Energy.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Rocket Stocks for Gluttonous Turkey Day Gains: Boeing and More

Thanksgiving week has a distinct bullish bias for the stock market.

Time to Sell These 5 'Toxic' Stocks: Bitauto Holdings and More

For investors looking to buy one of these positions, it makes sense to wait for more favorable technical conditions (and a lower share price) before piling in.

5 Earnings Short-Squeeze Plays: Workday, Trina Solar and More

You only need to find a few short-squeeze plays to juice your annual returns.

Must-See Charts: How to Trade IBM, Applied Materials and More

Skilled technical traders can bank gains as much as 90% of the time.

5 Stocks With Big Insider Trading: Groupon, Jive Software and More

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

MainStreet

Professional Boomers Are Not Immune to the U.S. Savings Crisis and Millennials are Falling Behind

Why and how life insurance, reverse mortgages and annuities can help aging boomers save money quickly for retirement

5 Lawyers to Watch in 2015 as Medical and Recreational Pot Gather Steam

National employers are challenged with a patchwork of marijuana drug testing policies to work through

Obama’s Immigration Action May Unleash Environmental and Worker Health Claims

Industries that rely on undocumented immigrant workers might have to budget over coming years for an uptick in claims for environmental and safety violations.

Meet The Moneyman Behind Florida’s Amendment 2 Campaign: Bob Morgan

Analysis of Florida's medical marijuana vote - the only state reform campaign to "lose" in 2014 by winning a majority.

New Study Indicates Long-term Effects of Weed Use on Brain, Dire Implications for Pot Proponents

A report published in the prestigious Proceedings of the National Academy of Sciences is bad news for weed legalization proponents.

Biotech

BioMarin Acquires Prosensa in Deal Valued Up to $840 Million

Biomarin is betting its experience in securing approvals for "orphan disease" drugs can help Prosensa win approval for drisapersen, an experimental treatment for Duchenne muscular dystrophy.

Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma

The $3.3 billion paid by Royalty Pharma to the Cystic Fibrosis Foundation to acquire royalty rights to Vertex Pharmaceuticals' cystic fibrosis drugs suggests investors are under-estimating peak sales.

Beyond Wall St.

Deal News

BioMarin Acquires Prosensa in Deal Valued Up to $840 Million

Biomarin is betting its experience in securing approvals for "orphan disease" drugs can help Prosensa win approval for drisapersen, an experimental treatment for Duchenne muscular dystrophy.

Aviva in Talks to Buy Friends Life for $8.8B in Stock Deal

Britain's Aviva is in talks to buy another insurer, Friends for Life for $8.8 billion.

Halliburton Buys Baker, Actavis Snares Allergan & Stanton's Big Deal

Halliburton announced it will buy fellow oil services giant Baker Hughes this week for about $35 billion in cash and stock.

TheStreetTV
Spin Space

Jim Cramer

PPG Is Spot-On; The Hazards of Skepticism: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about PPG's Mexico deal and the market's amazing run.

Herb Greenberg

Greenberg: How Hertz Fooled So Many Hedge Fund Managers

But suing Audit Integrity wasn't such a good idea.

Stephanie Link

Dicker/Link: Tubular Bells Offshore Project Begins Production - but No Reason Yet to Invest

Dan Dicker talks with Stephanie Link, co-portfolio director of Action Alerts, about the beginnings of production of a $2.3 billion offshore project co-owned by Hess and Chevron.

Chris Ciaccia

Intel's Mobile Future Seems on Track After Analyst Day: What Wall Street's Saying

Intel shares tacked on gains following a sharp run-up after the company held its analyst day, announcing 2015 guidance, soothing investors' about the future of the world's largest ...

Adam Feuerstein

BioMarin Acquires Prosensa in Deal Valued Up to $840 Million

Biomarin is betting its experience in securing approvals for "orphan disease" drugs can help Prosensa win approval for drisapersen, an experimental treatment for Duchenne muscular ...

Dan Freed

Are Google, Facebook and Alibaba More Dangerous Than the NSA?

The question isn’t easy to answer, says first amendment scholar and University of Chicago Professor Geoffrey Stone.

Ted Reed

A Small Step in American/US Air Merger Becomes Something More

American and US Airways ticket counters in Charlotte moved closer together on Friday, and employees made that into something more.

Leon Lazaroff

Aereo May Be Dead, But Over-The-Top Television Is Just Beginning

Aereo's bankruptcy brings to an end a company that filled the public's demand for choice and mobility. Another provider would be wise to acquire its technology.

Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs